Comparing different vaccine adjuvants for flu and certain infections
Adjuvant Comparison and Characterization in Influenza , Chlamydia muridarum, and Coxiella burnetii Vaccines
This study is looking at how different ingredients can make flu and certain bacterial vaccines work better, so that people can get stronger protection against these illnesses.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-11122155 on NIH RePORTER |
What this research studies
This research investigates how different adjuvants enhance the effectiveness of vaccines against influenza and specific bacterial infections. By comparing these adjuvants side-by-side, the study aims to create detailed immune profiles that show how each adjuvant works in the body. Patients may benefit from improved vaccine formulations that provide better protection against these diseases. The research involves analyzing immune responses in various tissues to understand the best combinations for vaccine development.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for influenza or infections caused by Chlamydia muridarum and Coxiella burnetii.
Not a fit: Patients who are not at risk for these infections or who have already been vaccinated may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective vaccines that provide better protection against influenza and certain bacterial infections.
How similar studies have performed: Previous research has shown promise in enhancing vaccine efficacy through adjuvant optimization, indicating that this approach could yield beneficial results.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Felgner, Philip — University of California-Irvine
- Study coordinator: Felgner, Philip
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.